Trial Profile
Efficacy of EGb 761® 120mg Twice a Day Versus Placebo on Cognitive Impairment in Patients With Multiple Sclerosis. A Randomised, Double-blind, Multicentre, Parallel Groups Placebo Controlled Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Cognition disorders
- Focus Registrational; Therapeutic Use
- Sponsors Ipsen
- 02 Apr 2014 New trial record